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Introduction: Hepatokines such as fibroblast growth factor 21 (FGF21), follistatin and 
leukocyte cell-derived chemotaxin 2 (LECT2) are liver-derived proteins which contribute to 
the regulation of whole-body glucose and lipid metabolism. Acute shifts in energy balance, 
through means such as exercise, modulate circulating concentrations of these hepatokines; 
however the influence of exercise intensity has not been fully explored. This study examined 
the effect of exercise intensity on circulating hepatokine concentrations in healthy men.  
Methods: In a randomized, crossover design, 10 healthy men (see Table 1 for participant 
characteristics) completed three experimental trials, commencing with either a moderate-
intensity run (55% peak oxygen uptake (V̇O2 peak); MOD), high-intensity run (75% V̇O2 
peak; HIGH) or control period (rest; CON). The duration of MOD and HIGH differed (mean 
± SD: 57 ± 8 vs 42 ± 6 min, respectively) so that total energy expenditure was matched 
(target 600 kcal). After exercise, participants rested for 7 h, with standardised meals 
consumed at 2 and 6 h post-exercise. Venous blood samples were taken before exercise and 
at 0, 1, 2, 4 and 7 h post-exercise for measurement of plasma FGF21, follistatin and LECT2 
concentrations (ELISA). 
Results:  Total energy expenditure was similar between the two exercise trials (MOD vs 
HIGH: 591 ± 17 vs 595 ± 14 kcal; P = 0.46). Two-way ANOVA revealed a significant trial 
main effect and trial-time interaction for FGF21 (both P < 0.001), indicating a greater 
increase in plasma FGF21 concentrations at 1, 2 and 4 h after HIGH compared to MOD (all P 
< 0.03; Figure 1A). A significant trial main effect and trial-time interaction for follistatin was 
also observed, indicating elevated plasma follistatin concentrations at 4 and 7 h after both 
MOD and HIGH vs CON (all P < 0.01; Figure 1B); however the response was similar 
between the two exercise trials. A significant trial-time interaction was found for LECT2, 
indicating an increase in plasma LECT2 concentrations immediately after MOD and HIGH 
vs CON (both P < 0.05; Figure 1C); however there were no differences between the two 
exercise trials. 
Discussion: The present study demonstrates that acute bouts of exercise transiently increase 
circulating concentrations of the hepatokines FGF21, follistatin and LECT2. Furthermore, the 
magnitude of the post-exercise increase in circulating FGF21 may be dependent on the 
intensity of the exercise, while responses in the other hepatokines appear to be independent of 
exercise intensity. 
  
Table 1. Participant characteristics (n = 10). 
              Mean ± SD 
Age (years) 26 ± 2 
Height (m) 1.77 ± 0.07 
Body mass (kg) 80.2 ± 6.2 
BMI (kg.m-2) 25.6 ± 1.7 
Waist circumference (cm) 83.7 ± 4.1 
Body fat (%) 15.4 ± 4.4 
V̇O2 peak (ml•kg-1•min-1) 49.8 ± 5.3 
  BMI, body mass index; V̇O2 peak, peak oxygen uptake. 
 
 
